Racial Differences in Vagal Control of Glucose Homeostasis

Trial Profile

Racial Differences in Vagal Control of Glucose Homeostasis

Phase of Trial: Phase I/II

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Galantamine (Primary)
  • Indications Obesity
  • Focus Pharmacodynamics
  • Most Recent Events

    • 22 Feb 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Oct 2017.
    • 10 Dec 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 25 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top